Hiroaki Nagano

Establishment of an experimental model of normal dog bladder organoid using a three-dimensional culture method.

H. Yamawaki, D. Azakami, T. Omatsu, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Randomized phase III study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401‐ MITSUBA)

H. Eguchi, E. Hatano, Shogo Kobayashi, 2022, Journal of hepato-biliary-pancreatic sciences.

Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)

M. Kudo, K. Ueshima, U. Motosugi, 2023, Hepatology research : the official journal of the Japan Society of Hepatology.

Revisions of the clinical practice guidelines for hepatocellular carcinoma in 2021 version

M. Kudo, K. Ueshima, U. Motosugi, 2023, Kanzo.

Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial

R. Higuchi, H. Katayama, J. Furuse, 2023, The Lancet.

Short‐ and long‐term outcomes of laparoscopic radical gallbladder resection for gallbladder carcinoma: A multi‐institutional retrospective study in Japan

Y. Abe, Y. Takeda, M. Kitago, 2023, Journal of hepato-biliary-pancreatic sciences.

Randomized phase III study of gemcitabine, cisplatin plus S-1 (GCS) versus gemcitabine, cisplatin (GC) for advanced biliary tract cancer (KHBO1401-MITSUBA).

H. Eguchi, C. Ishioka, E. Hatano, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Impact of Tumor Shrinkage Pattern with Biweekly Triplet Gemcitabine+Cisplatin+S-1 Regimen for Biliary Tract Cancers: Implications for Neoadjuvant Therapy from the Data of KHBO1401 (KHBO1401-1A Study)

Shogo Kobayashi, H. Kamachi, T. Ioka, 2023, Oncology.